BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 332337)

  • 1. Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.
    Chou TC; Arlin Z; Clarkson BD; Phillips FS
    Cancer Res; 1977 Oct; 37(10):3561-70. PubMed ID: 332337
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.
    Ho DH; Carter CJ; Brown NS; Hester J; McCredie K; Benjamin RS; Freireich EJ; Bodey GP
    Cancer Res; 1980 Jul; 40(7):2444-6. PubMed ID: 6248205
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow cells.
    Creasey WA; DeConti RC; Kaplan SR
    Cancer Res; 1968 Jun; 28(6):1074-81. PubMed ID: 5241767
    [No Abstract]   [Full Text] [Related]  

  • 4. Separation of leukemic cells into proliferative and quiescent subpopulations by centrifugal elutriation.
    Preisler HD; Walczak I; Renick J; Rustum YM
    Cancer Res; 1977 Nov; 37(11):3876-80. PubMed ID: 71201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-beta-D-arabinofuranosylcytosine (ara-C) deamination in human leukemic myeloblasts is not a mechanism of resistance to ara-C therapy.
    Harris AL
    Cancer Res; 1981 Jul; 41(7):2977-9. PubMed ID: 6941850
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).
    Riva CM; Rustum YM; Preisler HD
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):1-8. PubMed ID: 3859925
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy.
    Rustum YM; Preisler HD
    Cancer Res; 1979 Jan; 39(1):42-9. PubMed ID: 282940
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the antineoplastic alkaloid acronycine on nucleoside uptake and incorporation into nucleic acids by cultured L5178Y cells.
    Dunn BP; Gout PW; Beer CT
    Cancer Res; 1973 Oct; 33(10):2310-9. PubMed ID: 4517733
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.
    Momparler RL; Onetto-Pothier N; Bouffard DY; Momparler LF
    Cancer Chemother Pharmacol; 1990; 27(2):141-6. PubMed ID: 2249330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S; Lehman C; Cadman E
    Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolism of bone marrow leukocyte elements in chronic myeloid leukemia].
    Lapotnikov VA; Lebedeva NP; Moskalik IG; Onushchenko IA; Filev LV
    Probl Gematol Pereliv Krovi; 1972 Feb; 17(2):3-6. PubMed ID: 4505857
    [No Abstract]   [Full Text] [Related]  

  • 12. The generation time of human leukemic myeloblasts.
    Greenberg ML; Chanana AD; Cronkite EP; Giacomelli G; Schiffer LM; Stryctmans PA; Vincent PC
    Lab Invest; 1972 Mar; 26(3):245-52. PubMed ID: 4502025
    [No Abstract]   [Full Text] [Related]  

  • 13. Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors.
    Burke PJ; Karp JE; Braine HG; Vaughan WP
    Cancer Res; 1977 Jul; 37(7 Pt 1):2138-46. PubMed ID: 266416
    [No Abstract]   [Full Text] [Related]  

  • 14. [A study of mitotic indices and H3-thymidine uptake of bone marrow and blood cells in patients with chronic granulocytic leukemia].
    Mamaev NN
    Tsitologiia; 1968 Jul; 10(7):880-8. PubMed ID: 5250031
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W; Hug V; Keating MJ; Chubb S
    Cancer Res; 1980 Mar; 40(3):588-91. PubMed ID: 6937239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia.
    Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R
    Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylation of nucleic acids in normal and leukemic leukocytes.
    Silber R; Berman E; Goldstein B; Stein H; Farnham G; Bertino JR
    Biochim Biophys Acta; 1966 Sep; 123(3):638-40. PubMed ID: 5230235
    [No Abstract]   [Full Text] [Related]  

  • 18. Proliferative activity of leukaemic cells at various stages of acute leukaemia of childhood.
    Foadi MD; Cooper EH; Hardisty RM
    Br J Haematol; 1968 Sep; 15(3):269-81. PubMed ID: 5245522
    [No Abstract]   [Full Text] [Related]  

  • 19. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
    Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of cell proliferation in acute leukemia.
    Cheung WH; Rai KR; Sawitsky A
    Cancer Res; 1972 May; 32(5):939-42. PubMed ID: 4502172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.